Financial Health Snapshot
What does CRH’s latest financial snapshot show about financial health?
Mixed. CRH’s strongest factor is cash generation, while the main concern is rising debt after acquisition activity.
As of FY 2025, CRH’s latest verified results point to a mixed financial profile. The verdict blends growth, profitability, cash generation, balance-sheet capacity, and capital efficiency, with strong operating performance offset by a heavier debt load.
For deeper analysis, the Mission Statement, Vision, & Core Values (2026) of CRH plc (CRH) page helps connect strategy to this capital profile, but the first metric to study closely is net debt.
Revenue Quality
Are CRH’s revenue growth and earnings quality strong enough to support financial health?
Mixed. CRH’s FY 2024 revenue rose 2% to $3560B, while net income and basic EPS grew faster, and FY 2025 net income and adjusted EBITDA improved again. The clearest confirmation is earnings momentum; the main divergence is that growth included acquisition-led expansion, not just same-store demand.
For context, CRH plc (CRH): History, Ownership, Mission, How It Works & Makes Money shows why investors watch this mix closely. Revenue growth tells you how much the business is scaling, but operating income, net income, and EPS show whether that growth is turning into real profit across the same annual periods.
| Measure | Latest Period | Previous Period | Quality Test | Investor Meaning |
|---|---|---|---|---|
| Revenue | $3560B in FY 2024, up 2% | $3490B in FY 2023 | Partly acquisition-led; underlying split not fully verified here | Growth looks steady, but repeatability is stronger when it comes from demand, pricing, or volume |
| Operating Income | $369B in the reported 2025-12-31 period | Previous comparable value not provided | Direction is positive, but a like-for-like annual comparison is unavailable | Useful as a profitability check, but the quality test is incomplete without a matched prior period |
| Net Income | $380B in FY 2025, up 8% | $350B in FY 2024 | Improved after higher operating profit; no unusual-item detail provided | Final earnings confirm the business is converting scale into profit |
| Diluted EPS | $221 in the reported 2025-12-31 period | Previous comparable diluted EPS not provided | Share-count effect cannot be tested from the supplied data | Per-share quality is harder to judge, so investors should pair this with cash flow and share issuance data |
How durable is CRH’s revenue?
Strong. The strongest durability signal is CRH’s exposure to North America, which generates approximately 75% of profits and ties demand to infrastructure and non-residential activity. The biggest visibility limit is that acquisition-led growth can make the revenue mix less clean to judge.
- Demand Quality: Revenue visibility is helped by infrastructure and non-residential demand, which is steadier than purely discretionary demand.
- Pricing and Volume: The supplied data do not separate verified price, volume, and mix effects.
- Diversification: North America dominates profit contribution, so geographic concentration remains a real factor even with broad operations.
FY 2025 also included about $410B invested across 38 acquisitions, so investors should now watch profitability and cash conversion, not just reported sales.
Profitability and cash quality
Does CRH convert profit into durable cash flow?
Yes, partly. CRH’s adjusted EBITDA margin improved to 19.50% in FY 2024 from 17.70%, and FY 2025 net cash from operating activities of $560B supports earnings quality. Free cash flow is harder to judge because FY 2025 growth capex of $170B and acquisition investment of $410B used a lot of cash.
CRH’s reported earnings look better when you separate margin trends from cash generation. Adjusted EBITDA and net income show profitability, but operating cash flow shows how much of that profit turned into cash. Capital spending and acquisitions then reduce what is left for free cash flow, dividends, and buybacks.
| Measure | Latest Period | Previous Period | Verified Driver | Investor Meaning |
|---|---|---|---|---|
| Gross Margin | FY 2024 adjusted EBITDA margin 19.50% | FY 2023 adjusted EBITDA margin 17.70% | Improved pricing, mix, and cost control lifted adjusted EBITDA margin by 180 basis points. | Product economics improved, even though this is adjusted EBITDA margin rather than gross margin. |
| Operating Margin | Unavailable in the supplied data | Unavailable in the supplied data | No verified operating margin figure was provided. | Scale appears helpful, but the exact operating efficiency trend cannot be confirmed here. |
| Net Margin | Unavailable in the supplied data | Unavailable in the supplied data | FY 2025 net income of $380B was provided, but no verified net margin figure was supplied. | Final profitability is positive, but the margin itself cannot be verified from the supplied data. |
| Operating Cash Flow | FY 2025 net cash from operating activities $560B | Unavailable in the supplied data | Cash generation remained strong alongside FY 2025 earnings. | Reported earnings are being converted into operating cash. |
| Free Cash Flow | Unavailable | Unavailable | FY 2025 growth capex of $170B and acquisition investment of $410B were major cash uses. | Residual cash for reinvestment and financing was pressured by expansion and deal activity. |
What most affects CRH’s cash conversion?
FY 2025 operating cash flow was strong, but cash conversion was mainly shaped by heavy acquisition spending and growth capex. That makes the underlying cash engine look solid, while free cash available to shareholders looks more dependent on investment intensity.
- Main Driver: Operating cash flow held up, but $410B of acquisition investment and $170B of growth capex made the effect look partly temporary.
- Evidence Gap: The supplied data does not provide a verified free cash flow figure or a full working-capital bridge.
- Metric to Monitor: Follow net cash from operating activities and capital spending together, plus the pace of buybacks and dividends.
If you’re using this topic for a paper or case study, a structured SWOT Analysis, PESTLE Analysis, or Business Model Canvas can help you organize the research into clear arguments. For a broader ownership angle, see Exploring CRH plc (CRH) Investor Profile: Who's Buying and Why?
Flexible but leveraged
How strong are CRH’s debt position and liquidity?
CRH’s balance sheet is Mixed. Debt is manageable because operating cash flow was $560B in FY 2025, but leverage has risen and the main concern is that acquisitions could keep debt growing faster than cash generation.
Cash by itself does not tell the full story, so the better test is whether CRH can cover working capital, service debt, and still fund investment without straining solvency or refinancing needs. The balance looks flexible, but it is more leveraged than before, and the link between cash flow and debt growth matters for future financial room. For background on the business model, see CRH plc (CRH): History, Ownership, Mission, How It Works & Makes Money.
| Area | Latest Evidence | Assessment | Investor Meaning |
|---|---|---|---|
| Cash and Working Capital | No verified current assets, current liabilities, receivables, inventory, or liquidity ratio was supplied; operating cash flow was $560B in FY 2025. | Mixed | Near-term obligations look supported by cash generation, but full short-term liquidity cannot be confirmed from the supplied data. |
| Total and Net Debt | Total debt was $1400B as of December 31, 2024, up from $1160B in 2023; net debt was $1420B as of December 31, 2025. | Mixed | Leverage is higher than before, so financial flexibility is present but not abundant. |
| Debt Service and Refinancing | FY 2025 operating cash flow of $560B supports debt service capacity; no verified maturities, interest expense, or credit-access data were supplied. | Mixed | Cash generation helps cover interest and principal, but refinancing risk cannot be judged in full from the available data. |
| Asset Quality | FMP enterprise value data lists Total Debt of $1971B and Minus Cash And Cash Equivalents of $410B for 2025-12-31, which gives context on leverage but not a full liquidity review. | Mixed | Asset quality appears serviceable from the data provided, but the main issue remains leverage tied to growth and acquisition activity. |
| Liabilities and Equity | No verified total liabilities or shareholders' equity figure was supplied for the latest period. | Mixed | Without the latest liability and equity totals, investors should focus on cash flow and debt trends rather than book capital alone. |
Which balance-sheet risk matters most for CRH?
The biggest risk is leverage drift: debt has climbed, and investors should watch whether acquisitions keep pushing debt up faster than operating cash flow.
- Current Exposure: Total debt was $1400B as of December 31, 2024, and net debt was $1420B as of December 31, 2025.
- Protection: FY 2025 operating cash flow of $560B is the clearest buffer for debt service and investment.
- Warning Signal: Watch whether debt keeps rising faster than cash flow, especially if acquisitions remain active.
Capital Efficiency
Is CRH using capital efficiently while reinvesting for growth?
CRH looks Strong, and internal cash appears sufficient for reinvestment needs based on its cash generation and disciplined buybacks, though large acquisitions and buyback activity still need monitoring.
Return measures should be read alongside leverage, asset intensity, capital expenditure, working capital, and outside funding needs. For CRH, the key question is not just whether returns are high, but whether growth spending and acquisitions can stay funded without stretching the balance sheet or limiting future flexibility.
| Capital Measure | Latest Evidence | Quality Test | Investor Meaning |
|---|---|---|---|
| ROIC | Return On Net Assets of 1550% in FY 2024, up 20 basis points from 2023. | Operating margins and capital efficiency support the result. | Invested capital appears to create operating value. |
| ROE and ROA | Not supplied. | Leverage and asset intensity cannot be tested here without values. | Shareholder return quality and asset efficiency are not verifiable from the provided data. |
| Maintenance and Growth Investment | FY 2025 growth capex was $170B, and acquisition investment was $410B across 38 acquisitions, including Eco Material Technologies for $210B. | These figures show active reinvestment, but maintenance versus growth spending is not separately disclosed. | CRH is putting substantial capital into organic expansion and strategic acquisitions to support future growth. |
| Internal Funding Capacity | $030B buyback tranches were completed on August 05, 2025, November 05, 2025, and February 17, 2026; $970B has been returned to shareholders via buybacks since May 2018. | Investment appears largely internally funded, with capital also directed to shareholder returns. | Strong cash generation supports reinvestment and distributions, but leverage could reduce future allocation flexibility. |
Are CRH's returns on capital sustainable?
Yes, mainly because CRH combines strong operating returns with repeated reinvestment and buybacks. Sustainability weakens if acquisition spending or leverage rises faster than cash flow.
- Operating Source: Strong operating margins and capital efficiency support the return profile.
- Funding Requirement: The largest verified capital need is $410B of acquisition investment, plus $170B of growth capex.
- Durability Test: A falling return on net assets, rising leverage, or weaker cash flow coverage would show returns weakening.
Debt Pressures
How resilient is CRH plc, and which warning signs matter most?
CRH plc’s resilience is Mixed. The main buffer is strong North American infrastructure exposure and FY 2025 operating cash flow of $560B. The most important verified warning sign is higher debt, with net debt at $1420B as of December 31, 2025, after acquisition investment.
CRH plc can still protect liquidity and keep investing, but resilience is not unlimited. The business has recurring infrastructure demand and about 75% of profit from North America, yet cash needs can rise if Europe stays weak, capital spending stays high, or acquisition activity keeps adding to leverage.
| Pressure | Financial Effect | Existing Protection | Warning Signal |
|---|---|---|---|
| Revenue or Margin Pressure | Weaker construction demand can reduce operating leverage, earnings, cash flow, and debt capacity if pricing and volume soften, especially in Europe. | North American infrastructure exposure and about 75% of profit from North America help offset subdued European new-build residential demand. | Watch for continued revenue weakness, lower margins, or falling operating cash flow in Europe and any broader decline in construction activity. |
| Working-Capital or Investment Pressure | Growth capex and acquisitions can absorb cash, leaving less room for debt reduction, dividends, or essential investment if operating cash flow slows. | FY 2025 operating cash flow of $560B provides internal funding capacity. | Watch for persistently high capex, more acquisition spending, or weaker cash conversion that leaves less free cash flow. |
| Interest or Refinancing Pressure | Higher debt can reduce interest coverage, tighten free cash flow, and limit flexibility if funding conditions worsen. | Operational cash generation and diversified earnings help support financing capacity. | Watch for rising net debt, higher interest expense, or signs that refinancing becomes more expensive. |
Which financial warning signs should investors monitor at CRH plc?
The top signals are net debt rising further, cash flow weakening, and European demand staying soft. The debt increase is confirmed deterioration; weak construction demand is a real operating risk, and continued capex or deal spending would make it more dangerous.
Rising net debt after acquisition spending
Net debt at $1420B is the clearest pressure point. The exposure is lower financing flexibility if borrowing keeps rising. The mitigating factor is strong cash generation. Monitor net debt and interest coverage.
Soft European construction demand
Subdued new-build residential activity in 2024 only partly offset by infrastructure demand shows earnings pressure in Europe. The risk is lower volume and margin support. Monitor regional sales and margin trends for further deterioration.
Cash absorbed by capex and acquisitions
CRH plc invested $170B of growth capex in 2025 and $410B in acquisitions. That supports long-term growth, but it also uses cash that could otherwise reduce debt. Monitor free cash flow after investment.
Financial Health Scorecard
What does CRH's financial health mean for investors?
CRH’s overall score is Strong, led by cash generation and earnings quality, while the weakest factor is balance sheet leverage. The most important investment condition is whether operating cash flow stays strong enough to support debt and reinvestment. For a related investor angle, see Exploring CRH plc (CRH) Investor Profile: Who's Buying and Why?
| Financial Factor | Rating | Evidence and Investor Meaning |
|---|---|---|
| Revenue and Earnings Quality | Strong | FY 2025 net income of $380B and adjusted EBITDA of $770B show solid earnings conversion and support per-share results. |
| Profitability and Cash | Strong | FY 2025 operating cash flow of $560B and FY 2024 adjusted EBITDA margin of 1950% point to strong cash generation. |
| Balance Sheet and Liquidity | Mixed | Net debt of $1420B as of December 31, 2025 supports growth, but leverage remains a real constraint on flexibility. |
| Capital Efficiency | Strong | Return On Net Assets of 1550% in FY 2024 and disciplined reinvestment suggest efficient use of capital. |
| Financial Resilience | Mixed | North American demand helps, but debt and Europe softness remain watch items, so resilience is supportive but not risk-free. |
- What Supports the Thesis: Strong cash generation, solid earnings quality, and disciplined reinvestment create a durable financial base.
- What Challenges the Thesis: Net debt of $1420B and Europe softness could limit flexibility if demand weakens.
- What to Monitor: net debt, net cash from operating activities, and adjusted EBITDA.
This profile supports scenario analysis because forecasts should test whether cash flow stays ahead of debt service and reinvestment needs under different demand assumptions.
FAQ
What Do Investors Ask About 's Financial Health?
Investors most often ask about the company's revenue quality, profitability, cash generation, debt, liquidity, capital efficiency, and ability to withstand financial pressure.
How much operating cash flow does CRH generate?
CRH reported net cash from operating activities of $560B in FY 2025 That supports its financial health because operating cash helps fund capex, acquisitions, dividends, buybacks, and debt service without relying only on external financing
Why is CRH net debt rising after acquisitions?
Net debt reached $1420B as of December 31, 2025, after CRH invested $410B in 38 acquisitions during FY 2025 The higher debt is not automatically negative, but investors should track whether acquired earnings and cash flow offset the added leverage
What does CRH adjusted EBITDA margin show?
CRH reported an adjusted EBITDA margin of 1950% in FY 2024, up 180 basis points from the previous year That indicates improved operating profitability, but investors should avoid assuming the same margin for FY 2025 unless a verified FY 2025 margin is supplied
How sustainable are CRH buybacks and dividends?
CRH continued shareholder returns through dividends and repeated $030B buyback tranches while also generating $560B of operating cash flow in FY 2025 Sustainability depends on future cash generation, acquisition spending, capex needs, and the path of net debt
What should investors monitor for CRH liquidity?
Investors should monitor net debt, net cash from operating activities, and adjusted EBITDA These three metrics show whether CRH can keep funding operations, reinvestment, acquisitions, and shareholder returns while maintaining balance-sheet flexibility